ArticleCureus2026
Management of Fragility Femoral Fractures: A UK Regional Multicentre Audit of the British Orthopaedic Association Standards for Trauma (BOAST) Guidelines.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Fragility fractures of the femur, excluding the neck of the femur (NOF), are increasingly common and associated with significant morbidity in the older population. Current best practice in the UK recommends that surgery should permit full weight bearing (FWB) and be performed within 36 hours of admission. Methods A multicentre retrospective audit was conducted across patients admitted to seven NHS hospitals in the UK in 2021. Patients aged ≥65 years with low-energy, non-NOF femoral fragility fractures who underwent surgery were included. Data were collected on fracture classification, operative treatment, weight-bearing prescription and achievement, time to surgery, length of stay, and discharge destination. Results A total of 358 patients met the inclusion criteria: hip periprosthetic fractures (n = 171, 48%), distal femur fractures (n = 67, 19%), midshaft fractures (n = 65, 18%), and knee periprosthetic fractures (n = 55, 15%). Fixation was the predominant treatment (n = 303, 85%), with plating being the most common. Joint arthroplasty (n = 54, 15%) was associated with more permissive postoperative prescriptions than fixation (n = 41 (76%) vs. n = 173 (57%)). Of 342 patients with time-to-surgery data, only 86 (25%) received surgery within 36 hours. Arthroplasty procedures more frequently breached this timeframe (n = 46, 85%) when compared to fixation (n = 218, 72%). Median length of stay was shorter when surgery occurred within 36 hours (13 days vs. 17 days). Weight-bearing prescription was not associated with length of stay, but was associated with discharge destination. FWB patients were more frequently discharged home. Conclusion In the UK, fixation remains the most common treatment for non-NOF fragility femoral fractures, despite being associated with less permissive weight-bearing prescriptions and less independent discharge outcomes than arthroplasty. Delay beyond 36 hours was common, particularly in arthroplasty cases, and was associated with prolonged hospital stay. Improved access to revision arthroplasty surgeons is required to achieve compliance with the British Orthopaedic Association Standards for Trauma (BOAST) guidance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.